ACTIV TRACE support at NCBI for SARS-CoV-2
$2,354,179N02FY2023LMNIH
A-Tek, Inc., Ellicott City MD
Investigators
Abstract
To monitor and evaluate SARS-CoV-2 genome evolution and characterize representative variant viruses for their potential impact on medical countermeasures.
View original record on NIH RePORTER →